A detailed history of Clearstead Trust, LLC transactions in Viatris Inc stock. As of the latest transaction made, Clearstead Trust, LLC holds 44 shares of VTRS stock, worth $545. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Previous 44 -0.0%
Holding current value
$545
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$10.05 - $12.02 $412 - $492
-41 Reduced 48.24%
44 $0
Q1 2024

May 10, 2024

BUY
$11.27 - $13.53 $462 - $554
41 Added 93.18%
85 $1,000
Q4 2023

Feb 06, 2024

SELL
$8.77 - $10.85 $1,490 - $1,844
-170 Reduced 79.44%
44 $0
Q2 2023

Aug 08, 2023

SELL
$9.02 - $10.29 $739 - $843
-82 Reduced 27.7%
214 $2,000
Q1 2023

May 10, 2023

SELL
$9.2 - $12.26 $2,143 - $2,856
-233 Reduced 44.05%
296 $2,000
Q4 2022

Jan 31, 2023

SELL
$8.72 - $11.56 $2,554 - $3,387
-293 Reduced 35.64%
529 $6,000
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $6,970 - $9,148
822 New
822 $7,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.